SleepWell Trade

Trend-Following Backtester · Guide · backtest 한국어

equity · US

Corbus Pharmaceuticals Holdings, Inc. backtest

10 trend-following strategies were compared on the full daily history of Corbus Pharmaceuticals Holdings, Inc.. 10 beat buy-and-hold CAGR; ADX / DI 방향성 ranks first by Sharpe, matching the main backtester. The return/drawdown alternative is ADX / DI 방향성 (CAGR 9.5%, MDD -51.0%).

Data 2014-10-27 ~ 2026-07-31daily bars 2,957 (11.8 years)Costs 0.5%Venue XNASMonthly snapshot 2026-07-31

Results by strategy

10 of 10 beat buy and hold (CAGR -17.8%, drawdown -99.3%).

Sharpe leader (same as main): ADX / DI 방향성 — CAGR 9.5%, MDD -51.0%, Sharpe 0.42, 11% exposure.

Return/drawdown alternative: ADX / DI 방향성 — CAGR is 27.4%p higher than buy and hold, while drawdown improves by 48.3%p (CAGR 9.5%, MDD -51.0%, exposure 11%).

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
ADX / DI 방향성
period=45, threshold=24
9.5%-51.0%0.420.192.9x811%
SMA 크로스오버
fast=38, slow=69
8.6%-89.2%0.420.102.6x3644%
MACD
fast=18, slow=53, signal=18
3.7%-92.5%0.420.041.5x9956%
Donchian 채널 돌파
entryN=7, exitN=44
-4.6%-97.9%0.42-0.050.6x6573%
ROC 모멘텀
n=53, threshold=-0.02
-0.1%-94.8%0.38-0.001.0x13445%
Supertrend
period=12, mult=4.3
-2.2%-95.5%0.38-0.020.8x3446%
Keltner 채널 돌파
emaPeriod=33, atrPeriod=16, mult=3.9
7.3%-60.2%0.380.122.3x1610%
EMA 크로스오버
fast=43, slow=84
1.1%-90.8%0.380.011.1x2439%
볼린저 밴드 돌파
n=35, k=3.1
5.9%-75.2%0.340.082.0x1811%
Parabolic SAR
step=0.03, maxStep=0.18
-3.4%-89.2%0.28-0.040.7x28144%
Buy and hold-17.8%-99.3%0.36-0.180.1x1100%
0.1 1x 2015 2017 2019 2021 2023 2025 ADX / DI 방향성Buy and hold
ADX / DI 방향성: Solid strategy line versus dashed buy-and-hold line. Log scale.
0% -25% -50% -74% -99% 2015 2017 2019 2021 2023 2025 Buy and holdADX / DI 방향성
ADX / DI 방향성 maximum drawdown -51.0% (2016-10-07 → 2016-11-03), recovered after 2,702 days.

Rules of the top strategy

Looks at both the direction and the strength of the trend; holds only in a strong uptrend.

Method and caveats

Past performance does not guarantee future returns. Parameters were selected on the same full-history sample using sharpe over 40 trials per strategy, so results contain in-sample bias. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-run the same setupMore US assetsAll asset reports

Read next